1 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Rogaratinib: new trials by email Literature Review of Rogaratinib trials Research Report on Rogaratinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma Rogaratinib (BAY1163877), Chemotherapy - Carcinoma, Transitional Cell | Phase 2 / Phase 3 | Completed | Bayer | 175 | 2018-05-31 | 2022-09-28 |
Carcinoma, Transitional Cell (1)
Bayer (1)
Australia (1) · Austria (1) · Belgium (1) · Canada (1) · China (1) · Czechia (1) · Denmark (1) · Finland (1) · France (1) · Germany (1) · Hong Kong (1) · Hungary (1) · Ireland (1) · Israel (1) · Italy (1)
2016 (1)